Vista Pharmaceuticals Ltd. (BSE: 524711) is a Hyderabad, Telangana-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹40 Cr, it ranks #3,943 by market cap among the 6,197 Indian listed companies on FinBizNet, and #8 of 9 in Non-Prescription Drugs. At ₹6.17 (as of 16 Nov 2026), the share price is 38.9% below its 52-week high of ₹10.10 and 16.0% above its 52-week low of ₹5.32. The share price is down 37.1% over one year and down 9.4% over three months.
| Current Price | ₹6.17 |
|---|---|
| Market Cap | ₹40 Cr |
| BSE Code | 524711 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Non-Prescription Drugs |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -10.82% |
| Return on Assets | -4.89% |
| 52-Week Range | ₹5.32 – ₹10.10 |
| 1-Year Price Change | -37.1% |
| 3-Month Price Change | -9.4% |
| Beta (1Y) | 0.55 |
| Headquarters | Hyderabad, Telangana |
| Website | www.vistapharmaceuticals.com |
Delivery averaged 85.4% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. The company was incorporated in 1991 and is based in Hyderabad, India.
1. Manufacturing of Pharmaceutical Products-This segment manufactures and sells pharmaceutical, medical, and veterinary preparations.
1. Manufacturing of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | ₹44,982 Cr | 43.4 | 48.91% | ₹1,184 Cr | +3.3% |
| Alembic Pharmaceuticals Limited (Aplltd) | ₹20,245 Cr | 30.5 | 12.36% | ₹2,603 Cr | +11.7% |
| Bliss Gvs Pharma Ltd. | ₹6,817 Cr | 53.9 | 11.60% | ₹313 Cr | +426.3% |
| Zota Health Care Ltd | ₹4,585 Cr | n/m | -16.05% | ₹199 Cr | -15.1% |
| Amrutanjan Health Care Ltd. | ₹1,467 Cr | 25.3 | 16.62% | ₹135 Cr | -28.1% |
| Jenburkt Pharmaceuticals Ltd. | ₹433 Cr | 12.5 | 18.84% | — | -11.8% |
| Sat Kartar Life Limited | ₹256 Cr | 15.7 | 25.30% | — | — |
| Vista Pharmaceuticals Ltd. | ₹40 Cr | n/m | -10.82% | — | -37.1% |
| Welcure Drugs & Pharmaceuticals | ₹23 Cr | n/m | -5.50% | — | -64.2% |
Listed by market capitalisation. Ratios are shown for context only.
Vista Pharmaceuticals Ltd. is trading at ₹6.17, with a market capitalisation of ₹40 Cr.
Vista Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).
Vista Pharmaceuticals Ltd. has a return on equity of -10.82%.
Vista Pharmaceuticals Ltd. is listed on the BSE under the scrip code 524711.
Vista Pharmaceuticals Ltd.'s share price is down 37.1% over one year and down 9.4% over three months. Its 52-week range is ₹5.32 to ₹10.10.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.